Compass Therapeutics, Inc.
CMPX$277M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaBOSTON35 employees
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
Aug 10, 2026
7wMarket Overview
Stock performance and key metrics
CMPX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
CTX-009
Metastatic Colorectal Cancer
Paclitaxel
Biliary Tract Cancer
Psilocybin
Post Traumatic Stress Disorder
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CTX-009 | Phase 3 | Metastatic Colorectal Cancer | - | - |
Paclitaxel | Phase 3 | Biliary Tract Cancer | - | - |
Psilocybin | Phase 3 | Post Traumatic Stress Disorder | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply